Textbook of benign prostatic hyperplasia /

Textbook of benign prostatic hyperplasia /

Saved in:
Bibliographic Details
Imprint:Oxford : Isis Medical Media ; Aylesford, Kent, UK : Distributed by Times Mirror International Publishers, 1996.
Description:x, 566 p. : ill.
Language:English
Subject:
Prostatic Hyperplasia -- drug therapy.
Prostatic Hyperplasia -- diagnosis.
Prostatic Hyperplasia -- surgery.
Adrenergic alpha-Antagonists -- therapeutic use.
Prostate -- Hypertrophy.
Prostate -- Hypertrophy -- Treatment.
Prostate -- Hypertrophy.
Prostate -- Hypertrophy -- Treatment.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/2555396
Hidden Bibliographic Details
Other authors / contributors:Kirby, R. S. (Roger S.)
ISBN:1899066241
Notes:Includes bibliographical references and index.

MARC

LEADER 00000cam a2200000 a 4500
001 2555396
003 ICU
005 20030522185700.0
008 970107s1996 enk 000 0 eng d
010 |a gb 96045229  
015 |a GB96-45229 
020 |a 1899066241 
035 |a (ICU)BID22719366 
035 |a (OCoLC)34974556 
040 |a NLM  |c NLM  |d UKM  |d CUX  |d ICU  |d OrLoB-B  |d OCoLC 
041 0 |a eng 
060 0 |a 1996 H-630 
060 0 |a WJ 752  |b T355 1996 
082 0 4 |a 616.65  |2 20 
245 0 0 |a Textbook of benign prostatic hyperplasia /  |c edited by Roger Kirby ... [et al.]. 
260 |a Oxford :  |b Isis Medical Media ;  |a Aylesford, Kent, UK :  |b Distributed by Times Mirror International Publishers,  |c 1996. 
300 |a x, 566 p. :  |b ill. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g 1.  |t Macro-anatomy of the prostate /  |r J. S. Dixon and J. A. Gosling --  |g 2.  |t Embryology and development of the prostate /  |r E. Shapiro and M. S. Steiner --  |g 3.  |t Molecular control of prostate growth /  |r K. Griffiths --  |g 4.  |t Stromal-epithelial interactions: molecular aspects and relevance to benign prostatic hyperplasia /  |r M. R. Freeman, M. E. Gleave and L. W. K. Chung --  |g 5.  |t Prostatic adrenoceptors /  |r B. A. Kenny, A. M. Naylor and M. G. Wyllie --  |g 6.  |t 5 Alpha-reductase in prostate disease /  |r J. D. McConnell --  |g 7.  |t Pathology of benign prostatic hyperplasia /  |r D. G. Bostwick --  |g 8.  |t Bladder responses to obstruction /  |r J. D. McConnell --  |g 9.  |t Molecular genetics of benign prostatic hyperplasia /  |r M. C. W. Voller and J. A. Schalken --  |g 10.  |t Population-based studies of benign prostatic hyperplasia /  |r H. A. Guess --  |g 11.  |t Natural history of benign prostatic hyperplasia /  |r J. B. Meigs and M. J. Barry --  |g 12.  |t Evaluating symptoms and functional status /  |r M. P. O'Leary and M. J. Barry --  |g 13.  |t Clinical assessment: digital rectal examination /  |r L. J. Denis --  |g 14.  |t Prostate specific antigen and cancer assessment /  |r C. T. Lee and J. E. Oesterling --  |g 15.  |t Flow rate and post-void residual issues /  |r E. P. Arnold --  |g 16.  |t Urodynamics and benign prostatic hyperplasia /  |r A. Te and S. Kaplan --  |g 17.  |t Imaging and benign prostatic hyperplasia /  |r D. Rickards --  |g 18.  |t The role and interpretation of core biopsies in clinical benign prostatic hyperplasia /  |r M. R. Feneley and M. C. Parkinson --  |g 19.  |t Neurological and neurophysiological assessment /  |r C. J. Fowler and R. S. Kirby --  |g 20.  |t Watchful waiting /  |r F. A. Madson and R. C. Bruskewitz --  |g 21.  |t The placebo effect in the treatment of benign prostatic hyperplasia /  |r C. G. Roehrborn --  |g 22.  |t Finasteride therapy for benign prostatic hyperplasia /  |r J. D. McConnell --  |g 23.  |t Epristeride: a new 5 alpha-reductase inhibitor for the treatment of benign prostatic hyperplasia /  |r C. R. Chapple, Y. J. Lamb, R. K. Knight and M. A. Levy --  |g 24.  |t Other hormonal treatments /  |r J. D. McConnell --  |g 25.  |t Terazosin for the treatment of benign prostatic hyperplasia /  |r H. Lepor --  |g 26.  |t Doxazosin in the treatment of obstruction of the lower urinary tract /  |r R. S. Kirby --  |g 27.  |t Alfuzosin /  |r A. Jardin --  |g 28.  |t Tamsulosin /  |r C. C. Schulman --  |g 29.  |t Combination therapies for benign hyperplasia /  |r R. S. Kirby and H. Lepor --  |g 30.  |t Phytotherapeutic agents /  |r J. M. Fitzpatrick and T. H. Lynch --  |g 31.  |t Standard surgical interventions: TUIP/TURP/OPSU /  |r C. G. Roehrborn --  |g 32.  |t Laser prostatectomy /  |r B. S. Stein --  |g 33.  |t Interstitial laser coagulation /  |r T. A. McNicholas and M. Al-Sudani --  |g 34.  |t Hyperthermia treatment for benign prostatic hyperplasia /  |r M. L. Blute and R. L. Lewis --  |g 35.  |t Transurethral thermotherapy /  |r M. A. Devonec --  |g 36.  |t Transurethral needle ablation of the prostate /  |r C. C. Schulman and A. R. Zlotta --  |g 37.  |t High-intensity focused ultrasound /  |r S. Madersbacher and M. Marberger --  |g 38.  |t Transurethral balloon dilation of the prostate /  |r J. A. Vale and T. J. Christmas --  |g 39.  |t Temporary stents /  |r J. Nordling --  |g 40.  |t Prostatic endoprosthetics /  |r A. E. Te and S. A. Kaplan --  |g 41.  |t Transurethral electro-vaporization of the prostate /  |r B. J. Miles and L. Sirls --  |g 42.  |t Treatment outcomes and their interpretation in benign prostatic hyperplasia /  |r C. G. Roehrborn --  |g 43.  |t Guidelines for diagnosis and management of benign prostatic hyperplasia /  |r J. D. McConnell --  |g 44.  |t Economics of benign prostatic hyperplasia /  |r H. L. Holtgrewe --  |g 45.  |t Shared care for benign prostatic hyperplasia /  |r R. S. Kirby, J. M. Fitzpatrick, M. G. Kirby and A. Fitzpatrick --  |g 46.  |t Prostate diseases beyond the year 2000: present and future burden of prostate diseases /  |r P. Boyle, P. Maisonneuve and P. Napalkov. 
650 1 2 |a Prostatic Hyperplasia  |x drug therapy. 
650 2 2 |a Prostatic Hyperplasia  |x diagnosis. 
650 2 2 |a Prostatic Hyperplasia  |x surgery. 
650 2 2 |a Adrenergic alpha-Antagonists  |x therapeutic use. 
650 0 |a Prostate  |x Hypertrophy.  |0 http://id.loc.gov/authorities/subjects/sh85107609 
650 0 |a Prostate  |x Hypertrophy  |x Treatment. 
653 0 |a Men  |a Prostate gland 
650 7 |a Prostate  |x Hypertrophy.  |2 fast  |0 http://id.worldcat.org/fast/fst01079505 
650 7 |a Prostate  |x Hypertrophy  |x Treatment.  |2 fast  |0 http://id.worldcat.org/fast/fst01079506 
700 1 |a Kirby, R. S.  |q (Roger S.)  |0 http://id.loc.gov/authorities/names/n89122386  |1 http://viaf.org/viaf/42540788 
901 |a ToCBNA 
903 |a HeVa 
929 |a cat 
999 f f |i 10f31d22-db12-58f0-8c41-9222df6d8886  |s 2be09cad-2d90-5009-96a6-fb3bbef7830e 
928 |t Library of Congress classification  |a RC899.T598 1996  |l ASR  |c ASR-SciASR  |i 3266080 
927 |t Library of Congress classification  |a RC899.T598 1996  |l ASR  |c ASR-SciASR  |e belf  |e CRERAR  |b 44373148  |i 4735883 
Purchased from the William T. Belfield Fund for the John Crerar Library bookplate
The John Crerar Library bookplate

Similar Items